Literature DB >> 16006001

Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline.

Chia-Ming Chu1, Yun-Fan Liaw.   

Abstract

BACKGROUND/AIMS: Longitudinal studies on the relationship between hepatitis B virus (HBV) genotypes and reactivation of hepatitis B and progression to cirrhosis were very rare.
METHODS: Liver biochemistry, virological markers and ultrasound were monitored in 202 hepatitis B e antigen (HBeAg)-positive patients with normal alanine aminotransferase (ALT) at baseline for 3-20 (average 10.8) years, and the outcome was correlated with HBV genotypes.
RESULTS: There were 150 genotype B and 52 genotype C patients. Hepatitis activity during the HBeAg-positive phase showed no significant difference. However, genotype B was associated with a significantly earlier and higher rate of HBeAg seroconversion. HBeAg seroconversion correlated with age at entry for genotype B and with ALT levels for genotype C. Reactivation of hepatitis B was significantly more common in genotype C patients. Five genotype B and 10 genotype C patients progressed to cirrhosis. Multivariate analysis revealed that genotype C (P = 0.03) and reactivation of hepatitis B (P = 0.0004) were independent factor predictive of cirrhosis.
CONCLUSIONS: Rate and factors of HBeAg seroconversion, and rate of reactivation of hepatitis B differed between genotype B and genotype C patients. Genotype C and reactivation of hepatitis B were associated with increased risk of cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16006001     DOI: 10.1016/j.jhep.2005.03.018

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  53 in total

1.  Viral load, genotypes, and mutants in hepatitis B virus-related hepatocellular carcinoma: special emphasis on patients with early hepatocellular carcinoma.

Authors:  Chia-Ming Chu; Chen-Chun Lin; Shi-Ming Lin; Deng-Yn Lin; Yun-Fan Liaw
Journal:  Dig Dis Sci       Date:  2011-08-12       Impact factor: 3.199

2.  Simultaneous genotyping and quantification of hepatitis B virus for genotypes B and C by real-time PCR assay.

Authors:  Yao Zhao; Xiu-Yu Zhang; Jin-Jun Guo; Ai-Zhong Zeng; Jie-Li Hu; Wen-Xiang Huang; You-Lan Shan; Ai-Long Huang
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

3.  Relationship between genotypes and clinical manifestation, pathology, and cccDNA in Chinese children with hepatitis B virus-associated glomerulonephritis.

Authors:  Yong-Hong Sun; Xiao-Yan Lei; Yi-Pa Sai; Jun-Hui Chen; Yuan-Chun Sun; Xia Gao
Journal:  World J Pediatr       Date:  2016-04-08       Impact factor: 2.764

Review 4.  Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance.

Authors:  Catherine Mn Croagh; Paul V Desmond; Sally J Bell
Journal:  World J Hepatol       Date:  2015-03-27

Review 5.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2019-06-12

Review 6.  Genetic variation of hepatitis B virus and its significance for pathogenesis.

Authors:  Zhen-Hua Zhang; Chun-Chen Wu; Xin-Wen Chen; Xu Li; Jun Li; Meng-Ji Lu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

7.  Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt.

Authors:  Abeer Elkady; Sahar Aboulfotuh; Elsayed Mostafa Ali; Douaa Sayed; Nashwa M Abdel-Aziz; Amany M Ali; Shuko Murakami; Sayuki Iijima; Yasuhito Tanaka
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

8.  Protocol liver biopsies in long-term management of patients transplanted for hepatitis B-related liver disease.

Authors:  Stefano Targhetta; Federico Villamil; Paolo Inturri; Patrizia Pontisso; Stefano Fagiuoli; Umberto Cillo; Attilio Cecchetto; Simona Gianni; Remo Naccarato; Patrizia Burra
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 9.  Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.

Authors:  Cristina Della Corte; Alessio Aghemo; Massimo Colombo
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

10.  Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update.

Authors:  Yun-Fan Liaw; Nancy Leung; Jia-Horng Kao; Teerha Piratvisuth; Edward Gane; Kwang-Hyub Han; Richard Guan; George K K Lau; Stephen Locarnini
Journal:  Hepatol Int       Date:  2008-05-10       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.